Representative render — packaging may vary
Tirzepatide
Also indexed as LY3298176 · GIP/GLP-1 dual agonist
All products currently listed on this site are for research purposes only.
A lipidated 39-residue dual agonist of the GIP and GLP-1 receptors, and the reference compound for incretin co-agonism studies.
Size
$59.00
$69.00
per unit · EP-TIR-005
Add 4 more to reach $53.00 per unit.
| Quantity | Unit price | Saving |
|---|---|---|
| 1–4 | $59.00 | — |
| 5+ | $53.00 | 10% |
| 10+ | $47.00 | 20% |
Certificate of analysis
Lot EP-TIR-2606A
99.4%
Assayed purity
Guaranteed floor 99%
- Tested
- June 19, 2026
- Laboratory
- Janoshik Analytical
- Methods
- HPLCLC-MS
Literature
Research context
Tirzepatide is a synthetic peptide built on an exendin-like backbone with two α-aminoisobutyric acid substitutions and a C20 fatty diacid conjugated at Lys20. The published literature examines its biased signalling at GIPR and GLP-1R, receptor internalisation kinetics, and comparative potency against selective agonists in cell-based cAMP assays.
Documented research areas
- Dual GIP/GLP-1 receptor agonism
- Biased receptor signalling and β-arrestin recruitment
- cAMP accumulation assays
- Fatty-acid conjugation and albumin binding
Specification
Chemistry
- CAS number
- 2023788-19-2
- Molecular formula
- C225H348N48O68
- Molecular weight
- 4813.45 g/mol
- Form
- Lyophilized powder
- Purity floor
- ≥ 99%
- Appears in
- 4 documented research areas
- Amino acid sequence
- YAibEGTFTSDYSIAibLDKIAQKAFVQWLIAGGPSSGAPPPS-NH2 (Lys20 γGlu-C20 diacid)
Laboratory
Storage and handling
Storage
Store lyophilized powder at -20°C, protected from light and moisture.
Handling
For laboratory use by qualified personnel only.
Research use only. This material is supplied for laboratory research by qualified personnel. It is not a drug, food, cosmetic or household product, and it is not for human or veterinary use. See our research use policy and prohibited uses.
Sources
Selected references
- Coskun et al., Mol Metab (2018) — LY3298176 dual GIP/GLP-1 receptor agonist
- Willard et al., JCI Insight (2020) — Tirzepatide receptor signalling bias
External links open in a new tab. Ethereal Peptides is not affiliated with the publishers or the authors listed.
Nearby
Studied alongside
Incretin & Metabolic5-Amino-1MQ
5-amino-1-methylquinolinium
A quaternary quinolinium small molecule described in the literature as a selective inhibitor of nicotinamide N-methyltransferase.
Capsule≥98.5% purityLot assayed 99%From
$59.00
2 sizes
Research Use Only- Incretin & Metabolic
Tesofensine
NS2330
A tropane-derived small molecule characterised in the literature as a triple reuptake inhibitor of noradrenaline, dopamine and serotonin.
Capsule≥98.5% purityLot assayed 98.9%From
$89.00
1 size
Research Use Only 
NewIncretin & MetabolicSurvodutide
BI 456906
A 29-residue dual agonist of the glucagon and GLP-1 receptors carrying a C18 fatty-acid conjugate.
Lyophilized powder≥99% purityLot assayed 98.8%From
$139.00
1 size
Research Use Only